Valneva Faces Sales Drop in 2025, Hopes for Turnaround with New Vaccines
Valneva, a company specializing in travel vaccines, saw a decrease in product sales in 2025 due to market restrictions on […]
Lario Therapeutics Gets $2.4 Million to Develop New Brain Disorder Treatments
Lario Therapeutics, a company based in Edinburgh, has received $2.4 million in new funding from The Michael J Fox Foundation
Pharmaceutical News
New Research Brings Us Closer to Digital Pill Design
A recent study has found that understanding how pills break and how soft or hard they are could help us
Madrigal Pharmaceuticals Expands Treatment Options for Liver Disease MASH
Madrigal Pharmaceuticals, the first company to get U.S. approval for a medicine treating the common liver disease MASH, is now
Big Pharma’s Push for Easier, Faster Cancer Treatments
Big drug companies are working hard to make cancer treatments called CAR-T cell therapies more accessible. These treatments have been
Pharmaceutical News
Novartis Strengthens Case for Full Approval of Vanrafia in Kidney Disease
In 2026, Novartis is making progress in getting full approval for their drug Vanrafia to treat IgA nephropathy, a type
Sanofi Gets a New Leader: What This Means for the Future
Sanofi, a big French drug company, has a new CEO. Paul Hudson is stepping down after six years. During his
New Group Aims to Boost Investment in Europe’s Health and Biotech Startups
A new group called the European Life Sciences Coalition has started in Brussels. Its goal is to encourage more investment
New Company Aims to Fight Cancer with Personalized Vaccines
A company called Kahimmune Therapeutics, which focuses on cancer treatments that boost the immune system, has made a special deal
Big Pharma’s Race to Create the Next Big Weight Loss Drug
A fierce competition is happening among pharmaceutical companies to create the next groundbreaking weight loss drug. While the first generation